LIVZON PHARMA Publishes 8 Sep 2026 Circular and First EGM Notice; Highlights Shift to E-Communication

Bulletin Express
09/08

On 8 September 2026, Livzon Pharmaceutical Group Inc. (LIVZON PHARMA) released two key corporate documents on both its corporate website (www.livzon.com.cn) and Hong Kong Stock Exchange’s HKEXnews platform:

• Circular dated 8 September 2026 • Notice and Proxy Form for the 2026 First Extraordinary General Meeting (EGM)

The company emphasizes digital access, recommending shareholders consult the online versions to expedite information flow and reduce printing costs. Shareholders who previously elected to receive hard copies will find the printed package enclosed with the notification.

Action options for registered shareholders: 1. Continue with electronic delivery—ensure a valid email address is on file to receive future publication alerts and actionable communications. 2. Switch to printed copies—complete and return the enclosed request form to Tricor Investor Services Limited, 17/F, Far East Finance Centre, 16 Harcourt Road, Hong Kong, using the prepaid label or email 1513-ecom@vistra.com. Printed materials will be provided free of charge.

Deadlines and contacts: • The current instruction on preferred communication format remains valid until 31 December 2026 unless revised by written notice. • Shareholder enquiries can be directed to Tricor’s hotline at +852 2980 1333 (09:00–18:00, Monday–Friday, excluding public holidays).

The notification underscores shareholders’ responsibility to maintain an active email address; absent a functional address, the company will default to mailing physical notices until digital details are updated.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10